Root Financial Partners
VNDA icon

Root Financial Partners’s Vanda Pharmaceuticals VNDA Stock Holding History

Root Financial Partners’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.83K Buy
+373
New +$2K ﹤0.01% 2687
2026
Q2 		– Sell
-245
Closed -$1.69K – 3104
2026
Q1 		$1.69K Buy
+245
New +$1.89K ﹤0.01% 2388

Other funds holding VNDA

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Root Financial Partners's VNDA Position: Q3 2026 in Review

Root Financial Partners opened a new position in Vanda Pharmaceuticals (VNDA) in Q3 2026: 373 shares worth $1.83K. The stake represents ﹤0.01% of the portfolio and ranks #2687 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in VNDA as recently as Q1 2026.

Root Financial Partners first reported a position in VNDA in Q1 2026 and has held it in 2 quarters since. 90 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.

  • Root Financial Partners held 373 shares of Vanda Pharmaceuticals worth $1.83K as of Q3 2026.
  • Vanda Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2687 holding.
  • Root Financial Partners first reported a position in Vanda Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 90 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.